155 related articles for article (PubMed ID: 33777924)
1. Recent Advances in Nanomedicine for the Diagnosis and Therapy of Liver Fibrosis.
Bai X; Su G; Zhai S
Nanomaterials (Basel); 2020 Sep; 10(10):. PubMed ID: 33003520
[TBL] [Abstract][Full Text] [Related]
2. Current State of Melanoma Therapy and Next Steps: Battling Therapeutic Resistance.
Fateeva A; Eddy K; Chen S
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672652
[TBL] [Abstract][Full Text] [Related]
3. Applications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration.
Li Z; Shan X; Chen Z; Gao N; Zeng W; Zeng X; Mei L
Adv Sci (Weinh); 2020 Jan; 8(1):2002589. PubMed ID: 33437580
[TBL] [Abstract][Full Text] [Related]
4. Emerging 2D Nanomaterials for Multimodel Theranostics of Cancer.
Zhu W; Li H; Luo P
Front Bioeng Biotechnol; 2021; 9():769178. PubMed ID: 34869283
[No Abstract] [Full Text] [Related]
5. Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review).
Volovat SR; Negru S; Stolniceanu CR; Volovat C; Lungulescu C; Scripcariu D; Cobzeanu BM; Stefanescu C; Grigorescu C; Augustin I; Lupascu Ursulescu C; Volovat CC
Exp Ther Med; 2021 May; 21(5):535. PubMed ID: 33815608
[TBL] [Abstract][Full Text] [Related]
6. Systemic Therapy of Metastatic Melanoma: On the Road to Cure.
Steininger J; Gellrich FF; Schulz A; Westphal D; Beissert S; Meier F
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804800
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Long-term complete response to PSMA-targeted radioligand therapy and abiraterone in a metastatic prostate cancer patient.
Parker D; Zambelli J; Lara MK; Wolf TH; McDonald A; Lee E; Abou-Elkacem L; Gordon EJ; Baum RP
Front Oncol; 2023; 13():1192792. PubMed ID: 37188199
[TBL] [Abstract][Full Text] [Related]
8. Chemokines as possible therapeutic targets in metastatic melanoma.
Basson C; Serem JC; Bipath P; Hlophe YN
Cancer Med; 2023 Jul; 12(13):14387-14402. PubMed ID: 37170733
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape.
Battaglia L; Scomparin A; Dianzani C; Milla P; Muntoni E; Arpicco S; Cavalli R
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683910
[TBL] [Abstract][Full Text] [Related]
10. Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer.
Mukherjee A; Paul M; Mukherjee S
Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035440
[TBL] [Abstract][Full Text] [Related]
11. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
[TBL] [Abstract][Full Text] [Related]
12. Recent Progress in Nanomedicine for Melanoma Theranostics With Emphasis on Combination Therapy.
Guan M; Zhu S; Li S
Front Bioeng Biotechnol; 2021; 9():661214. PubMed ID: 33777924
[TBL] [Abstract][Full Text] [Related]
13. Functionalization of Nanomaterials and Their Application in Melanoma Cancer Theranostics.
Madamsetty VS; Paul MK; Mukherjee A; Mukherjee S
ACS Biomater Sci Eng; 2020 Jan; 6(1):167-181. PubMed ID: 33463233
[TBL] [Abstract][Full Text] [Related]
14. Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics.
Chen J; Shao R; Zhang XD; Chen C
Int J Nanomedicine; 2013; 8():2677-88. PubMed ID: 23926430
[TBL] [Abstract][Full Text] [Related]
15. Recent developments in nanomedicine for melanoma treatment.
Tang JQ; Hou XY; Yang CS; Li YX; Xin Y; Guo WW; Wei ZP; Liu YQ; Jiang G
Int J Cancer; 2017 Aug; 141(4):646-653. PubMed ID: 28340496
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
